Abstract
Sleep disturbances due to medications is a common problem. The effects can vary from mild insomnia to major alterations in sleep architecture. The factors affecting the sleep disturbances can be related to the patient or the drug. In this review article we have focused on the side effects due to medication commonly used in pulmonary medicine. The group of drugs discussed are corticosteroids, bronchodilators, leukotriene antagonists, methylxanthines, antihistamines, immunosuppressive medications and prostaglandins. Most evidence comes from studies involving small number of healthy volunteers, retrospective reports, or sleep disturbance reported during clinical trials. Though most of these medications have the potential to cause sleep disturbances, they may actually promote better sleep by improving the respiratory symptoms, especially in asthmatics and COPD patients. It is important that the clinician needs to be aware of these side effects so that the effects can be minimized by making appropriate adjustments to the drugs, making the patient aware of the side effects, counseling on good sleep hygiene and behavioral changes.
Keywords: Insomnia, sleep disturbances, medications, drugs, pulmonary drugs
Current Respiratory Medicine Reviews
Title: Sleep Disturbances Due to Pulmonary Medications
Volume: 5 Issue: 4
Author(s): Raghu M. Reddy and Shyamsunder Subramanian
Affiliation:
Keywords: Insomnia, sleep disturbances, medications, drugs, pulmonary drugs
Abstract: Sleep disturbances due to medications is a common problem. The effects can vary from mild insomnia to major alterations in sleep architecture. The factors affecting the sleep disturbances can be related to the patient or the drug. In this review article we have focused on the side effects due to medication commonly used in pulmonary medicine. The group of drugs discussed are corticosteroids, bronchodilators, leukotriene antagonists, methylxanthines, antihistamines, immunosuppressive medications and prostaglandins. Most evidence comes from studies involving small number of healthy volunteers, retrospective reports, or sleep disturbance reported during clinical trials. Though most of these medications have the potential to cause sleep disturbances, they may actually promote better sleep by improving the respiratory symptoms, especially in asthmatics and COPD patients. It is important that the clinician needs to be aware of these side effects so that the effects can be minimized by making appropriate adjustments to the drugs, making the patient aware of the side effects, counseling on good sleep hygiene and behavioral changes.
Export Options
About this article
Cite this article as:
Reddy M. Raghu and Subramanian Shyamsunder, Sleep Disturbances Due to Pulmonary Medications, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112393
DOI https://dx.doi.org/10.2174/157339809790112393 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium
Current Pharmaceutical Design Novel Anti-Inflammatory Agents in COPD: Targeting Lung and Systemic Inflammation
Current Drug Targets Rifaximin: An Antibiotic with Important Biologic Effects
Mini-Reviews in Medicinal Chemistry Assessment of Endothelial Function by Positron Emission Tomography
Current Cardiology Reviews Recent Patents on Rho Signaling Pathway as Therapeutic Target for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Experimental Diabetes Mellitus Down-Regulates Large-Conductance Ca2+- Activated K+ Channels in Cerebral Artery Smooth Muscle and Alters Functional Conductance
Current Neurovascular Research Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research Non-pharmacological Strategies Against Systemic Inflammation: Molecular Basis and Clinical Evidence
Current Pharmaceutical Design The Cardiac Antihypertrophic Effects of Cyclic GMP-Generating Agents: An Experimental Framework for Novel Treatments of Left Ventricular Remodeling
Vascular Disease Prevention (Discontinued) Maternity Waiting Homes in Rural Districts in Africa; A Cornerstone of Safe Motherhood?
Current Women`s Health Reviews IgA Nephropathy: Clinical Significance of Urinary Proteins/Polypeptides Characterization
Current Proteomics Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of Polymorphisms in Factor V (FV Leiden), Prothrombin, Plasminogen Activator Inhibitor Type-1 (PAI-1), Methylenetetrahydrofolate Reductase (MTHFR) and Cystathionine β-Synthase (CBS) Genes as Risk Factors for Thrombophilias
Mini-Reviews in Medicinal Chemistry Vascular Endothelin and Hypertension - From Receptors to Medicine
Current Hypertension Reviews Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway
Current Hypertension Reviews Transbronchial Needle Aspiration (TBNA): Past Present and Future
Current Respiratory Medicine Reviews Heart Failure in the Middle East
Current Cardiology Reviews Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Application of Endothelial Progenitor Cells for Treatment of Cardiovascular Diseases
Current Stem Cell Research & Therapy Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders